Last week saw high levels of activity in the IPO market, as eleven companies priced, making this month the first September to have 20 deals since September of 2000. Health care and technology companies continued to dominate the space, with nine of the...read more
Enzymotec, which develops lipid-based nutritional ingredients and medical foods, raised $62 million by offering 4.4 million shares at $14, below the range of $16 to $18. Enzymotec plans to list on the NASDAQ under the symbol ENZY. BofA Merrill Lynch and...read more
Rocket Fuel and FireEye had first-day returns (93% and 80%, respectively) to match their incendiary names last week, but neither could touch Benefitfocus's 102% first-day pop, just the tenth first-day double since 2000. The three represented the most 80%+...read more
US IPO Recap: Foundation Medicine soars, Chrysler revs up for an IPO
Last week saw high levels of activity in the IPO market, as eleven companies priced, making this month the first September to have 20 deals since September of 2000. Health care and technology companies continued to dominate the space, with nine of the...read more
Enzymotec prices at $14, below the range
Enzymotec, which develops lipid-based nutritional ingredients and medical foods, raised $62 million by offering 4.4 million shares at $14, below the range of $16 to $18. Enzymotec plans to list on the NASDAQ under the symbol ENZY. BofA Merrill Lynch and...read more
US IPO Recap: Blazing debuts for software trio FireEye, Rocket Fuel and Benefitfocus
Rocket Fuel and FireEye had first-day returns (93% and 80%, respectively) to match their incendiary names last week, but neither could touch Benefitfocus's 102% first-day pop, just the tenth first-day double since 2000. The three represented the most 80%+...read more
13 US IPOs planned for the week of Sep 23
The following IPOs are expected to price this week: Applied Optoelectronics (AAOI), a leading fiber-optic networking products provider, plans to raise $50 million by...read more